혈관 영상 시장

Global Vascular Imaging Market to Reach US$8.8 Billion by 2032

The global market for Vascular Imaging estimated at US$7.0 Billion in the year 2025, is expected to reach US$8.8 Billion by 2032, growing at a CAGR of 3.4% over the analysis period 2025-2032. CT Modality, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$3.2 Billion by the end of the analysis period. Growth in the MRI Modality segment is estimated at 4.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.9 Billion While China is Forecast to Grow at 6.4% CAGR

The Vascular Imaging market in the U.S. is estimated at US$1.9 Billion in the year 2025. China, the world's second largest economy, is forecast to reach a projected market size of US$1.9 Billion by the year 2032 trailing a CAGR of 6.4% over the analysis period 2025-2032. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.3% and 2.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.0% CAGR.

Global Vascular Imaging Market - Key Trends & Drivers Summarized

What Is Driving the Adoption of Vascular Imaging Technologies?

Vascular imaging technologies have become indispensable in the diagnosis and management of vascular diseases, offering detailed visualizations of blood vessels and circulatory systems. The increasing prevalence of cardiovascular and peripheral vascular diseases has led to a surge in the demand for advanced imaging modalities such as ultrasound, magnetic resonance angiography (MRA), and computed tomography angiography (CTA). These technologies provide critical insights into vascular conditions, enabling early diagnosis, precise treatment planning, and effective monitoring of disease progression. As healthcare providers strive to improve patient outcomes and reduce the burden of vascular diseases, the adoption of vascular imaging technologies is expected to grow, driving market expansion.

How Are Technological Advancements Enhancing Vascular Imaging?

Technological advancements have significantly enhanced the capabilities of vascular imaging, making it more accurate, non-invasive, and accessible. The development of high-resolution imaging systems and contrast agents has improved the clarity and detail of vascular images, allowing for better detection of abnormalities and blockages. The integration of artificial intelligence (AI) and machine learning algorithms into imaging systems has further revolutionized the field, enabling automated image analysis and predictive diagnostics. Additionally, innovations in portable and point-of-care imaging devices have made vascular imaging more accessible, particularly in remote or underserved regions. These technological advancements are driving the widespread adoption of vascular imaging technologies, as they offer greater precision and convenience in the diagnosis and management of vascular diseases.

What Are the Emerging Trends in Vascular Imaging?

The vascular imaging market is witnessing several emerging trends that are shaping its growth and development. One notable trend is the increasing use of hybrid imaging techniques, such as PET/CT and PET/MRI, which combine the strengths of different imaging modalities to provide more comprehensive and accurate assessments of vascular conditions. Another trend is the growing emphasis on non-invasive imaging methods, driven by the need to reduce patient discomfort and the risk of complications associated with invasive procedures. The rise in demand for personalized medicine is also influencing the market, as imaging technologies are increasingly being used to tailor treatment plans based on individual patient profiles. Furthermore, the expanding use of AI-driven imaging analytics is enabling more precise and faster interpretation of vascular images, improving diagnostic accuracy and efficiency.

What Factors Are Driving the Growth of the Vascular Imaging Market?

The growth in the vascular imaging market is driven by several factors, including the rising prevalence of vascular diseases such as atherosclerosis, aneurysms, and deep vein thrombosis. The increasing demand for early and accurate diagnosis, fueled by the growing awareness of the importance of preventive healthcare, is also a significant driver. Additionally, the continuous advancements in imaging technologies, including the development of more sophisticated and non-invasive imaging systems, are expanding the range of diagnostic options available to healthcare providers. The shift towards value-based care, which emphasizes the importance of accurate diagnostics in improving patient outcomes and reducing healthcare costs, is further boosting the adoption of vascular imaging technologies. Moreover, the growing focus on research and development in the field of vascular imaging, supported by government initiatives and funding, is contributing to the market's growth.

SCOPE OF STUDY:

The report analyzes the Vascular Imaging market by the following Segments, and Geographic Regions/Countries:

Segments:

Modality (CT Modality, MRI Modality, Ultrasound Modality, Nuclear Medicine Modality); End-Use (Hospitals End-Use, Imaging Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

SELECT PLAYERS -

• Abbott Laboratories
• Carestream Health, Inc.
• Esaote SpA
• Fujifilm Corporation
• GE Healthcare
• Hitachi Medical Corporation
• Hologic, Inc.
• Koninklijke Philips NV
• Samsung Medison Co., Ltd.
• Shimadzu Medical Systems USA
• Siemens AG
• Terumo Corporation
• Toshiba Corporation

WHAT SETS THIS REPORT APART FROM OTHERS?

Grounded in Domain Expert Perspectives - Incorporates perspectives emerging from domain experts across industry, enterprise and academia, adding context beyond conventional published research.

Captures Early Market Signals - Tracks shifts emerging through expert conversations, company activity and market-relevant discussions before they are fully reflected in traditional secondary research.

Draws From a Broad, Validated Intelligence Base - Brings together insights from conference sessions, keynotes, panel discussions, blogs, corporate disclosures, annual reports, institutional publications and other validated sources.

Connects Signals With Strategic Market Direction - Synthesizes these perspectives to identify where the market is moving, what is driving that movement and which developments are likely to matter most for strategy.

Provides In-Depth Company Intelligence - Extends beyond market-level analysis to examine the companies participating in and shaping the competitive environment.

Market Share Is Examined Where It Matters - A single global market share figure rarely tells the full story. Competitive structures can vary significantly across geographies. Where analytically relevant, Market Glass reports extend market share analysis into major regions with the level of detail tailored to the structure and dynamics of each market.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
  • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
  • Vascular Imaging - Global Key Competitors Percentage Market Share in 2026 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for 18 Players Worldwide in 2026 (E)
  • Global Economic Update
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Demand for Non-invasive Imaging Techniques
  • Technological Advancements in Vascular Ultrasound
  • Growth of MRI and CT Angiography in Vascular Diagnostics
  • Adoption of AI and Machine Learning in Vascular Imaging Analysis
  • Increasing Use of Portable and Handheld Imaging Devices
  • Expanding Applications of Vascular Imaging in Disease Screening
  • Innovations in Contrast Media and Imaging Agents
  • Integration of Imaging with Vascular Interventional Procedures
  • Growing Awareness and Early Diagnosis of Vascular Conditions
  • Cost-effectiveness and Accessibility of New Imaging Modalities
  • Rising Prevalence of Cardiovascular Diseases Globally
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Vascular Imaging Market Analysis of Annual Sales in US$ Million for Years 2020 through 2032
  • TABLE 2: World Recent Past, Current & Future Analysis for Vascular Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 3: World Historic Review for Vascular Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 4: World 13-Year Perspective for Vascular Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2020, 2026 & 2032
  • TABLE 5: World Recent Past, Current & Future Analysis for CT Modality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 6: World Historic Review for CT Modality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 7: World 13-Year Perspective for CT Modality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 8: World Recent Past, Current & Future Analysis for MRI Modality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 9: World Historic Review for MRI Modality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 10: World 13-Year Perspective for MRI Modality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 11: World Recent Past, Current & Future Analysis for Ultrasound Modality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 12: World Historic Review for Ultrasound Modality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 13: World 13-Year Perspective for Ultrasound Modality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 14: World Recent Past, Current & Future Analysis for Nuclear Medicine Modality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 15: World Historic Review for Nuclear Medicine Modality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 16: World 13-Year Perspective for Nuclear Medicine Modality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 18: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 19: World 13-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 20: World Recent Past, Current & Future Analysis for Imaging Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 21: World Historic Review for Imaging Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 22: World 13-Year Perspective for Imaging Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 23: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 24: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 25: World 13-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032

III. MARKET ANALYSIS

• UNITED STATES
  • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
  • TABLE 26: USA Recent Past, Current & Future Analysis for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 27: USA Historic Review for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 28: USA 13-Year Perspective for Vascular Imaging by Modality - Percentage Breakdown of Value Sales for CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality for the Years 2020, 2026 & 2032
  • TABLE 29: USA Recent Past, Current & Future Analysis for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 30: USA Historic Review for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 31: USA 13-Year Perspective for Vascular Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• CANADA
  • TABLE 32: Canada Recent Past, Current & Future Analysis for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 33: Canada Historic Review for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 34: Canada 13-Year Perspective for Vascular Imaging by Modality - Percentage Breakdown of Value Sales for CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality for the Years 2020, 2026 & 2032
  • TABLE 35: Canada Recent Past, Current & Future Analysis for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 36: Canada Historic Review for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 37: Canada 13-Year Perspective for Vascular Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• JAPAN
  • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
  • TABLE 38: Japan Recent Past, Current & Future Analysis for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 39: Japan Historic Review for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 40: Japan 13-Year Perspective for Vascular Imaging by Modality - Percentage Breakdown of Value Sales for CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality for the Years 2020, 2026 & 2032
  • TABLE 41: Japan Recent Past, Current & Future Analysis for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 42: Japan Historic Review for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 43: Japan 13-Year Perspective for Vascular Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• CHINA
  • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
  • TABLE 44: China Recent Past, Current & Future Analysis for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 45: China Historic Review for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 46: China 13-Year Perspective for Vascular Imaging by Modality - Percentage Breakdown of Value Sales for CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality for the Years 2020, 2026 & 2032
  • TABLE 47: China Recent Past, Current & Future Analysis for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 48: China Historic Review for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 49: China 13-Year Perspective for Vascular Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• EUROPE
  • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
  • TABLE 50: Europe Recent Past, Current & Future Analysis for Vascular Imaging by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 51: Europe Historic Review for Vascular Imaging by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 52: Europe 13-Year Perspective for Vascular Imaging by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2020, 2026 & 2032
  • TABLE 53: Europe Recent Past, Current & Future Analysis for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 54: Europe Historic Review for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 55: Europe 13-Year Perspective for Vascular Imaging by Modality - Percentage Breakdown of Value Sales for CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality for the Years 2020, 2026 & 2032
  • TABLE 56: Europe Recent Past, Current & Future Analysis for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 57: Europe Historic Review for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 58: Europe 13-Year Perspective for Vascular Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• FRANCE
  • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
  • TABLE 59: France Recent Past, Current & Future Analysis for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 60: France Historic Review for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 61: France 13-Year Perspective for Vascular Imaging by Modality - Percentage Breakdown of Value Sales for CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality for the Years 2020, 2026 & 2032
  • TABLE 62: France Recent Past, Current & Future Analysis for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 63: France Historic Review for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 64: France 13-Year Perspective for Vascular Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• GERMANY
  • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
  • TABLE 65: Germany Recent Past, Current & Future Analysis for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 66: Germany Historic Review for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 67: Germany 13-Year Perspective for Vascular Imaging by Modality - Percentage Breakdown of Value Sales for CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality for the Years 2020, 2026 & 2032
  • TABLE 68: Germany Recent Past, Current & Future Analysis for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 69: Germany Historic Review for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 70: Germany 13-Year Perspective for Vascular Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• ITALY
  • TABLE 71: Italy Recent Past, Current & Future Analysis for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 72: Italy Historic Review for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 73: Italy 13-Year Perspective for Vascular Imaging by Modality - Percentage Breakdown of Value Sales for CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality for the Years 2020, 2026 & 2032
  • TABLE 74: Italy Recent Past, Current & Future Analysis for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 75: Italy Historic Review for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 76: Italy 13-Year Perspective for Vascular Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• UNITED KINGDOM
  • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
  • TABLE 77: UK Recent Past, Current & Future Analysis for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 78: UK Historic Review for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 79: UK 13-Year Perspective for Vascular Imaging by Modality - Percentage Breakdown of Value Sales for CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality for the Years 2020, 2026 & 2032
  • TABLE 80: UK Recent Past, Current & Future Analysis for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 81: UK Historic Review for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 82: UK 13-Year Perspective for Vascular Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• SPAIN
  • TABLE 83: Spain Recent Past, Current & Future Analysis for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 84: Spain Historic Review for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 85: Spain 13-Year Perspective for Vascular Imaging by Modality - Percentage Breakdown of Value Sales for CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality for the Years 2020, 2026 & 2032
  • TABLE 86: Spain Recent Past, Current & Future Analysis for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 87: Spain Historic Review for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 88: Spain 13-Year Perspective for Vascular Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• RUSSIA
  • TABLE 89: Russia Recent Past, Current & Future Analysis for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 90: Russia Historic Review for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 91: Russia 13-Year Perspective for Vascular Imaging by Modality - Percentage Breakdown of Value Sales for CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality for the Years 2020, 2026 & 2032
  • TABLE 92: Russia Recent Past, Current & Future Analysis for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 93: Russia Historic Review for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 94: Russia 13-Year Perspective for Vascular Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• REST OF EUROPE
  • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 96: Rest of Europe Historic Review for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 97: Rest of Europe 13-Year Perspective for Vascular Imaging by Modality - Percentage Breakdown of Value Sales for CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality for the Years 2020, 2026 & 2032
  • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 99: Rest of Europe Historic Review for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 100: Rest of Europe 13-Year Perspective for Vascular Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• ASIA-PACIFIC
  • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2026 (E)
  • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Vascular Imaging by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 102: Asia-Pacific Historic Review for Vascular Imaging by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 103: Asia-Pacific 13-Year Perspective for Vascular Imaging by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2020, 2026 & 2032
  • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 105: Asia-Pacific Historic Review for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 106: Asia-Pacific 13-Year Perspective for Vascular Imaging by Modality - Percentage Breakdown of Value Sales for CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality for the Years 2020, 2026 & 2032
  • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 108: Asia-Pacific Historic Review for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 109: Asia-Pacific 13-Year Perspective for Vascular Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• AUSTRALIA
  • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2026 (E)
  • TABLE 110: Australia Recent Past, Current & Future Analysis for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 111: Australia Historic Review for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 112: Australia 13-Year Perspective for Vascular Imaging by Modality - Percentage Breakdown of Value Sales for CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality for the Years 2020, 2026 & 2032
  • TABLE 113: Australia Recent Past, Current & Future Analysis for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 114: Australia Historic Review for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 115: Australia 13-Year Perspective for Vascular Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• INDIA
  • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2026 (E)
  • TABLE 116: India Recent Past, Current & Future Analysis for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 117: India Historic Review for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 118: India 13-Year Perspective for Vascular Imaging by Modality - Percentage Breakdown of Value Sales for CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality for the Years 2020, 2026 & 2032
  • TABLE 119: India Recent Past, Current & Future Analysis for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 120: India Historic Review for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 121: India 13-Year Perspective for Vascular Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• SOUTH KOREA
  • TABLE 122: South Korea Recent Past, Current & Future Analysis for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 123: South Korea Historic Review for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 124: South Korea 13-Year Perspective for Vascular Imaging by Modality - Percentage Breakdown of Value Sales for CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality for the Years 2020, 2026 & 2032
  • TABLE 125: South Korea Recent Past, Current & Future Analysis for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 126: South Korea Historic Review for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 127: South Korea 13-Year Perspective for Vascular Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• REST OF ASIA-PACIFIC
  • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 129: Rest of Asia-Pacific Historic Review for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 130: Rest of Asia-Pacific 13-Year Perspective for Vascular Imaging by Modality - Percentage Breakdown of Value Sales for CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality for the Years 2020, 2026 & 2032
  • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 132: Rest of Asia-Pacific Historic Review for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 133: Rest of Asia-Pacific 13-Year Perspective for Vascular Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• LATIN AMERICA
  • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2026 (E)
  • TABLE 134: Latin America Recent Past, Current & Future Analysis for Vascular Imaging by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 135: Latin America Historic Review for Vascular Imaging by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 136: Latin America 13-Year Perspective for Vascular Imaging by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2020, 2026 & 2032
  • TABLE 137: Latin America Recent Past, Current & Future Analysis for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 138: Latin America Historic Review for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 139: Latin America 13-Year Perspective for Vascular Imaging by Modality - Percentage Breakdown of Value Sales for CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality for the Years 2020, 2026 & 2032
  • TABLE 140: Latin America Recent Past, Current & Future Analysis for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 141: Latin America Historic Review for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 142: Latin America 13-Year Perspective for Vascular Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• ARGENTINA
  • TABLE 143: Argentina Recent Past, Current & Future Analysis for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 144: Argentina Historic Review for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 145: Argentina 13-Year Perspective for Vascular Imaging by Modality - Percentage Breakdown of Value Sales for CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality for the Years 2020, 2026 & 2032
  • TABLE 146: Argentina Recent Past, Current & Future Analysis for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 147: Argentina Historic Review for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 148: Argentina 13-Year Perspective for Vascular Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• BRAZIL
  • TABLE 149: Brazil Recent Past, Current & Future Analysis for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 150: Brazil Historic Review for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 151: Brazil 13-Year Perspective for Vascular Imaging by Modality - Percentage Breakdown of Value Sales for CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality for the Years 2020, 2026 & 2032
  • TABLE 152: Brazil Recent Past, Current & Future Analysis for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 153: Brazil Historic Review for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 154: Brazil 13-Year Perspective for Vascular Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• MEXICO
  • TABLE 155: Mexico Recent Past, Current & Future Analysis for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 156: Mexico Historic Review for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 157: Mexico 13-Year Perspective for Vascular Imaging by Modality - Percentage Breakdown of Value Sales for CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality for the Years 2020, 2026 & 2032
  • TABLE 158: Mexico Recent Past, Current & Future Analysis for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 159: Mexico Historic Review for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 160: Mexico 13-Year Perspective for Vascular Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• REST OF LATIN AMERICA
  • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 162: Rest of Latin America Historic Review for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 163: Rest of Latin America 13-Year Perspective for Vascular Imaging by Modality - Percentage Breakdown of Value Sales for CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality for the Years 2020, 2026 & 2032
  • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 165: Rest of Latin America Historic Review for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 166: Rest of Latin America 13-Year Perspective for Vascular Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• MIDDLE EAST
  • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2026 (E)
  • TABLE 167: Middle East Recent Past, Current & Future Analysis for Vascular Imaging by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • TABLE 168: Middle East Historic Review for Vascular Imaging by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 169: Middle East 13-Year Perspective for Vascular Imaging by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2020, 2026 & 2032
  • TABLE 170: Middle East Recent Past, Current & Future Analysis for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 171: Middle East Historic Review for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 172: Middle East 13-Year Perspective for Vascular Imaging by Modality - Percentage Breakdown of Value Sales for CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality for the Years 2020, 2026 & 2032
  • TABLE 173: Middle East Recent Past, Current & Future Analysis for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 174: Middle East Historic Review for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 175: Middle East 13-Year Perspective for Vascular Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• IRAN
  • TABLE 176: Iran Recent Past, Current & Future Analysis for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 177: Iran Historic Review for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 178: Iran 13-Year Perspective for Vascular Imaging by Modality - Percentage Breakdown of Value Sales for CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality for the Years 2020, 2026 & 2032
  • TABLE 179: Iran Recent Past, Current & Future Analysis for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 180: Iran Historic Review for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 181: Iran 13-Year Perspective for Vascular Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• ISRAEL
  • TABLE 182: Israel Recent Past, Current & Future Analysis for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 183: Israel Historic Review for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 184: Israel 13-Year Perspective for Vascular Imaging by Modality - Percentage Breakdown of Value Sales for CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality for the Years 2020, 2026 & 2032
  • TABLE 185: Israel Recent Past, Current & Future Analysis for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 186: Israel Historic Review for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 187: Israel 13-Year Perspective for Vascular Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• SAUDI ARABIA
  • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 189: Saudi Arabia Historic Review for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 190: Saudi Arabia 13-Year Perspective for Vascular Imaging by Modality - Percentage Breakdown of Value Sales for CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality for the Years 2020, 2026 & 2032
  • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 192: Saudi Arabia Historic Review for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 193: Saudi Arabia 13-Year Perspective for Vascular Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• UNITED ARAB EMIRATES
  • TABLE 194: UAE Recent Past, Current & Future Analysis for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 195: UAE Historic Review for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 196: UAE 13-Year Perspective for Vascular Imaging by Modality - Percentage Breakdown of Value Sales for CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality for the Years 2020, 2026 & 2032
  • TABLE 197: UAE Recent Past, Current & Future Analysis for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 198: UAE Historic Review for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 199: UAE 13-Year Perspective for Vascular Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• REST OF MIDDLE EAST
  • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 201: Rest of Middle East Historic Review for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 202: Rest of Middle East 13-Year Perspective for Vascular Imaging by Modality - Percentage Breakdown of Value Sales for CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality for the Years 2020, 2026 & 2032
  • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 204: Rest of Middle East Historic Review for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 205: Rest of Middle East 13-Year Perspective for Vascular Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
• AFRICA
  • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2026 (E)
  • TABLE 206: Africa Recent Past, Current & Future Analysis for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 207: Africa Historic Review for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 208: Africa 13-Year Perspective for Vascular Imaging by Modality - Percentage Breakdown of Value Sales for CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality for the Years 2020, 2026 & 2032
  • TABLE 209: Africa Recent Past, Current & Future Analysis for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • TABLE 210: Africa Historic Review for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • TABLE 211: Africa 13-Year Perspective for Vascular Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032

IV. COMPETITION